Glucuronoxylomannan in the Cryptococcus species capsule as a target for CAR+ T-cell therapy
T. A. da Silva, P. J. Hauser, I. Bandey, T. Laskowski, Q. Wang, A. M. Najjar, P. Kumaresan
This paper demonstrates that GXMR-CAR+ T cells can effectively target and reduce Cryptococcus neoformans burden in a murine model.
bioRxiv · Jul 26, 2019Immunology